Polling Questions

< All Questions
According to the webcast:

with James G. Pfaus, PhD, IF
The melanocortin agonist bremelanotide is believed to increase sexual desire in women by which of the following mechanisms:
 Inhibition of serotonin release in the prefrontal cortex
 Activation of dopamine release in the medial preoptic area
 Activation of norepinephrine release in the nucleus accumbens
 Inhibition of progesterone release from the ovaries

Your answers are confidential and will be used for educational purposes only.